Recordati S.p.A. Updates on Share Buyback Program

The latest announcement is out from Recordati Industria Chimica e Farmaceutica SPA ( (IT:REC) ).

Recordati S.p.A. has announced updates on its share buyback program, initially disclosed to the market in November 2024. The program, executed with the support of UBS Europe SE, involves purchasing shares for management stock options and performance share plans. From January 6 to January 10, 2025, Recordati purchased 30,911 shares at an average price of €51.4585 on the MTA market. As of January 10, 2025, the company holds 2,849,970 shares, representing 1.363% of its share capital. This move is part of Recordati’s strategic efforts to support its incentive plans, potentially impacting its market positioning and shareholder value.

More about Recordati Industria Chimica e Farmaceutica SPA

Recordati Industria Chimica e Farmaceutica S.p.A. is an international pharmaceutical group listed on the Italian Stock Exchange. With a history rooted in a family pharmacy in Northern Italy in the 1920s, the company provides therapeutic options in specialized and general medicine, including rare diseases. Operating in about 150 countries across EMEA, Americas, and APAC regions, Recordati employs over 4,450 individuals and is committed to empowering people to address both common and rare health challenges.

YTD Price Performance: 4.05%

Average Trading Volume: 14,559

Technical Sentiment Consensus Rating: Strong Sell

Current Market Cap: €11.01B

See more insights into REC stock on TipRanks’ Stock Analysis page.